D. Ryan Daws

Chief Financial Officer, CONCERT PHARMACEUTICALS, INC.

Companies

enGene Therapeutics Inc.Chief financial officer Nov 29, 2023 to now¹
CONCERT PHARMACEUTICALS, INC.Chief financial officer Feb 12, 2014 to Jan 6, 2017²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARenGene Therapeutics Inc., Chief financial officer
2
SEC EDGARCONCERT PHARMACEUTICALS, INC., Chief financial officer